These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
596 related articles for article (PubMed ID: 22274918)
21. Visceral infiltration of intrahepatic cholangiocarcinoma is most prognostic after curative resection - Retrospective cohort study of 102 consecutive liver resections from a single center. Bartsch F; Baumgart J; Hoppe-Lotichius M; Schmidtmann I; Heinrich S; Lang H Int J Surg; 2018 Jul; 55():193-200. PubMed ID: 29803768 [TBL] [Abstract][Full Text] [Related]
22. Our experiences in surgical treatment for hilar cholangiocarcinoma. Maeno H; Ono T; Yamanoi A; Nagasue N Hepatogastroenterology; 2007; 54(75):669-73. PubMed ID: 17591038 [TBL] [Abstract][Full Text] [Related]
23. Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience. Scheuermann U; Kaths JM; Heise M; Pitton MB; Weinmann A; Hoppe-Lotichius M; Otto G Eur J Surg Oncol; 2013 Jun; 39(6):593-600. PubMed ID: 23611755 [TBL] [Abstract][Full Text] [Related]
24. Role of hilar resection in the treatment of hilar cholangiocarcinoma. Otani K; Chijiiwa K; Kai M; Ohuchida J; Nagano M; Kondo K Hepatogastroenterology; 2012 May; 59(115):696-700. PubMed ID: 22469711 [TBL] [Abstract][Full Text] [Related]
25. Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma. Ribero D; Amisano M; Lo Tesoriere R; Rosso S; Ferrero A; Capussotti L Ann Surg; 2011 Nov; 254(5):776-81; discussion 781-3. PubMed ID: 22042470 [TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study. Wiedmann M; Caca K; Berr F; Schiefke I; Tannapfel A; Wittekind C; Mössner J; Hauss J; Witzigmann H Cancer; 2003 Jun; 97(11):2783-90. PubMed ID: 12767091 [TBL] [Abstract][Full Text] [Related]
27. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Rea DJ; Munoz-Juarez M; Farnell MB; Donohue JH; Que FG; Crownhart B; Larson D; Nagorney DM Arch Surg; 2004 May; 139(5):514-23; discussion 523-5. PubMed ID: 15136352 [TBL] [Abstract][Full Text] [Related]
28. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection. Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199 [TBL] [Abstract][Full Text] [Related]
29. Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma. Nakagohri T; Asano T; Kinoshita H; Kenmochi T; Urashima T; Miura F; Ochiai T World J Surg; 2003 Mar; 27(3):289-93. PubMed ID: 12607053 [TBL] [Abstract][Full Text] [Related]
30. Extended bile duct resection and [corrected] liver and transplantation in patients with hilar cholangiocarcinoma: long-term results. Seehofer D; Thelen A; Neumann UP; Veltzke-Schlieker W; Denecke T; Kamphues C; Pratschke J; Jonas S; Neuhaus P Liver Transpl; 2009 Nov; 15(11):1499-507. PubMed ID: 19877250 [TBL] [Abstract][Full Text] [Related]
31. [Surgical approach in hilar cholangiocarcinoma]. Otto G Zentralbl Chir; 2006 Jun; 131(3):210-6. PubMed ID: 16739061 [TBL] [Abstract][Full Text] [Related]
32. Aggressive surgical resection for hilar cholangiocarcinoma. Lai EC; Lau WY ANZ J Surg; 2005 Nov; 75(11):981-5. PubMed ID: 16336393 [TBL] [Abstract][Full Text] [Related]
33. Survival analysis of intrahepatic cholangiocarcinoma after resection. Cho SY; Park SJ; Kim SH; Han SS; Kim YK; Lee KW; Lee SA; Hong EK; Lee WJ; Woo SM Ann Surg Oncol; 2010 Jul; 17(7):1823-30. PubMed ID: 20165987 [TBL] [Abstract][Full Text] [Related]
34. Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes. Baton O; Azoulay D; Adam DV; Castaing D J Am Coll Surg; 2007 Feb; 204(2):250-60. PubMed ID: 17254929 [TBL] [Abstract][Full Text] [Related]
35. Experience of surgical resection for hilar cholangiocarcinomas at a Japanese single cancer institute. Nanashima A; Tobinaga S; Abo T; Machino R; Takeshita H; Nonaka T; Hidaka S; Tanaka K; Kunizaki M; Sawai T; Yasutake T; Nagayasu T Hepatogastroenterology; 2012; 59(114):347-50. PubMed ID: 22353497 [TBL] [Abstract][Full Text] [Related]
36. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance]. Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908 [TBL] [Abstract][Full Text] [Related]
37. Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications. Hasegawa S; Ikai I; Fujii H; Hatano E; Shimahara Y World J Surg; 2007 Jun; 31(6):1256-63. PubMed ID: 17453285 [TBL] [Abstract][Full Text] [Related]
38. Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis. Yan Y; Lu N; Tian W; Liu T Tumori; 2014; 100(6):e250-6. PubMed ID: 25688507 [TBL] [Abstract][Full Text] [Related]
39. Clinicopathological factors impact the survival outcome following the resection of combined hepatocellular carcinoma and cholangiocarcinoma. Yap AQ; Chen CL; Yong CC; Kuo FY; Wang SH; Lin CC; Liu YW; Lin TL; Li WF; Millan CA; Wang CC Surg Oncol; 2013 Mar; 22(1):55-60. PubMed ID: 23102615 [TBL] [Abstract][Full Text] [Related]
40. Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients. Lang H; Sotiropoulos GC; Sgourakis G; Schmitz KJ; Paul A; Hilgard P; Zöpf T; Trarbach T; Malagó M; Baba HA; Broelsch CE J Am Coll Surg; 2009 Feb; 208(2):218-28. PubMed ID: 19228533 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]